Hugel is actively working to enhance the academic competitiveness of K-Aesthetic by supporting the translation of clinical data and procedural experiences from medical professionals into research papers and academic achievements.
On July 4, Hugel held the Hugel Scientific Exchange Symposium in Seoul's Gangnam district, attended by 40 domestic medical professionals.
The symposium featured practical training on the structure and publication process of aesthetic medical papers, as well as strategies for utilizing artificial intelligence (AI).
Speakers included Professor Han Hyung-min from Ajou University’s Department of Plastic Surgery, Director Lee Won from Yonsei Lee Won Plastic Surgery, and Professor Choi Su-in from Catholic University’s Department of Pharmacology, who shared research cases and publication experiences.
Hugel anticipates that the research outcomes of domestic medical professionals will lead to publications in international journals, thereby enhancing the credibility and professionalism of the domestic aesthetic industry through global academic exchanges.
Shin Seung-jun, Executive Director of Hugel's Medical Business Division, stated, "When clinical experiences and academic insights are accumulated in published form, it will serve as a crucial foundation for industry development. We aim to create meaningful medical evidence and contribute to the training of the next generation of medical professionals."
Meanwhile, the K-Aesthetic market is driven by foreign medical tourism demand and the expansion of global approvals. According to a report by KB Securities, foreign spending on dermatological services has reached record monthly highs, with the number of foreign patients receiving dermatological treatment increasing by an average of 143.3% over the past five years.
The report forecasts that the average overseas sales of Hugel, PharmaResearch, and Classys will grow by an annual average of 34.3% from 2025 to 2028, with the share of overseas sales expanding from 58.7% to 71.0%. It also highlighted that obtaining approvals in the so-called global big four markets— the United States, China, Europe, and Brazil—will be key to this growth.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.